市場調査レポート
商品コード
1582983

酵素結合免疫吸着測定法(ELISA)の世界市場、2024~2028年

Global Enzyme-linked Immunosorbent Assay (elisa) Market 2024-2028


出版日
発行
TechNavio
ページ情報
英文 192 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
酵素結合免疫吸着測定法(ELISA)の世界市場、2024~2028年
出版日: 2024年08月14日
発行: TechNavio
ページ情報: 英文 192 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

酵素結合免疫吸着測定法(ELISA)市場、2024~2028年

酵素結合免疫吸着測定法(ELISA)市場は2023~2028年に8億4,390万米ドル、予測期間中のCAGRは16.82%で成長すると予測されます。当レポートでは、酵素結合免疫吸着測定法(ELISA)市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。高齢化社会における頻繁な診断検査ニーズの高まり、食品産業における毒性検査の増加、慢性疾患の増加などが市場を牽引しています。

市場範囲
基準年 2024年
終了年 2028年
予測期間 2024~2028年
成長モメンタム 加速
前年比[2024年] 14.02%
CAGR 16.82%
増分額 8億4,390万米ドル

本調査では、今後数年間の酵素結合免疫吸着測定法(ELISA)市場成長を牽引する主要要因の1つとして、プロモーション活動の重要性の高まりを挙げています。また、がん患者の増加や新たな疾患対象の出現は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023年
  • 市場の展望 2023~2028年

第4章 市場規模実績

  • 酵素結合免疫吸着測定法(ELISA)の世界市場 2018~2022年
  • 用途別セグメント分析 2018~2022年
  • エンドユーザー別セグメント分析 2018~2022年
  • 地域別セグメント分析 2018~2022年
  • 国別セグメント分析 2018~2022年

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 用途別市場セグメンテーション

  • 市場セグメンテーション
  • 比較:用途別
  • ワクチン開発:市場規模と予測 2023~2028年
  • 免疫:市場規模と予測 2023~2028年
  • 診断:市場規模と予測 2023~2028年
  • 薬剤監視と製薬産業:市場規模と予測 2023~2028年
  • その他:市場規模と予測 2023~2028年
  • 用途別の市場機会

第7章 エンドユーザー別市場セグメンテーション

  • 市場セグメンテーション
  • 比較:エンドユーザー別
  • 病院と診断センター:市場規模と予測 2023~2028年
  • 研究所:市場規模と予測 2023~2028年
  • その他:市場規模と予測 2023~2028年
  • エンドユーザー別の市場機会

第8章 顧客情勢

  • 顧客情勢概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 比較:地域別
  • 北米:市場規模と予測 2023~2028年
  • 欧州:市場規模と予測 2023~2028年
  • アジア:市場規模と予測 2023~2028年
  • その他:市場規模と予測 2023~2028年
  • 米国:市場規模と予測 2023~2028年
  • 中国:市場規模と予測 2023~2028年
  • 英国:市場規模と予測 2023~2028年
  • ドイツ:市場規模と予測 2023~2028年
  • 日本:市場規模と予測 2023~2028年
  • 地域情勢別の市場機会

第10章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場課題
  • 促進要因と課題の影響
  • 市場機会・抑制要因

第11章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第12章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies Inc.
  • Avantor Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Danaher Corp.
  • Eppendorf SE
  • Merck KGaA
  • Novo Nordisk AS
  • Perkin Elmer Inc.
  • QIAGEN NV
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Enzyme-Linked Immunosorbent Assay (Elisa) Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Application - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Application
  • Exhibits35: Data Table on Comparison by Application
  • Exhibits36: Chart on Vaccine development - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Vaccine development - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Vaccine development - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Vaccine development - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Immunology - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Immunology - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Immunology - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Market opportunity by Application ($ million)
  • Exhibits57: Data Table on Market opportunity by Application ($ million)
  • Exhibits58: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits59: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits60: Chart on Comparison by End-user
  • Exhibits61: Data Table on Comparison by End-user
  • Exhibits62: Chart on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Data Table on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Chart on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Chart on Research laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Research laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Research laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Research laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Market opportunity by End-user ($ million)
  • Exhibits75: Data Table on Market opportunity by End-user ($ million)
  • Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits79: Chart on Geographic comparison
  • Exhibits80: Data Table on Geographic comparison
  • Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits114: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits115: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Market opportunity By Geographical Landscape ($ million)
  • Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits119: Impact of drivers and challenges in 2023 and 2028
  • Exhibits120: Overview on criticality of inputs and factors of differentiation
  • Exhibits121: Overview on factors of disruption
  • Exhibits122: Impact of key risks on business
  • Exhibits123: Companies covered
  • Exhibits124: Matrix on companies position and classification
  • Exhibits125: Abbott Laboratories - Overview
  • Exhibits126: Abbott Laboratories - Business segments
  • Exhibits127: Abbott Laboratories - Key news
  • Exhibits128: Abbott Laboratories - Key offerings
  • Exhibits129: Abbott Laboratories - Segment focus
  • Exhibits130: Abcam plc - Overview
  • Exhibits131: Abcam plc - Product / Service
  • Exhibits132: Abcam plc - Key news
  • Exhibits133: Abcam plc - Key offerings
  • Exhibits134: Agilent Technologies Inc. - Overview
  • Exhibits135: Agilent Technologies Inc. - Business segments
  • Exhibits136: Agilent Technologies Inc. - Key news
  • Exhibits137: Agilent Technologies Inc. - Key offerings
  • Exhibits138: Agilent Technologies Inc. - Segment focus
  • Exhibits139: Avantor Inc. - Overview
  • Exhibits140: Avantor Inc. - Business segments
  • Exhibits141: Avantor Inc. - Key news
  • Exhibits142: Avantor Inc. - Key offerings
  • Exhibits143: Avantor Inc. - Segment focus
  • Exhibits144: Becton Dickinson and Co. - Overview
  • Exhibits145: Becton Dickinson and Co. - Business segments
  • Exhibits146: Becton Dickinson and Co. - Key news
  • Exhibits147: Becton Dickinson and Co. - Key offerings
  • Exhibits148: Becton Dickinson and Co. - Segment focus
  • Exhibits149: Bio Rad Laboratories Inc. - Overview
  • Exhibits150: Bio Rad Laboratories Inc. - Business segments
  • Exhibits151: Bio Rad Laboratories Inc. - Key news
  • Exhibits152: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits153: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits154: bioMerieux SA - Overview
  • Exhibits155: bioMerieux SA - Product / Service
  • Exhibits156: bioMerieux SA - Key news
  • Exhibits157: bioMerieux SA - Key offerings
  • Exhibits158: Danaher Corp. - Overview
  • Exhibits159: Danaher Corp. - Business segments
  • Exhibits160: Danaher Corp. - Key news
  • Exhibits161: Danaher Corp. - Key offerings
  • Exhibits162: Danaher Corp. - Segment focus
  • Exhibits163: Eppendorf SE - Overview
  • Exhibits164: Eppendorf SE - Product / Service
  • Exhibits165: Eppendorf SE - Key news
  • Exhibits166: Eppendorf SE - Key offerings
  • Exhibits167: Merck KGaA - Overview
  • Exhibits168: Merck KGaA - Business segments
  • Exhibits169: Merck KGaA - Key news
  • Exhibits170: Merck KGaA - Key offerings
  • Exhibits171: Merck KGaA - Segment focus
  • Exhibits172: Novo Nordisk AS - Overview
  • Exhibits173: Novo Nordisk AS - Business segments
  • Exhibits174: Novo Nordisk AS - Key news
  • Exhibits175: Novo Nordisk AS - Key offerings
  • Exhibits176: Novo Nordisk AS - Segment focus
  • Exhibits177: Perkin Elmer Inc. - Overview
  • Exhibits178: Perkin Elmer Inc. - Business segments
  • Exhibits179: Perkin Elmer Inc. - Key news
  • Exhibits180: Perkin Elmer Inc. - Key offerings
  • Exhibits181: Perkin Elmer Inc. - Segment focus
  • Exhibits182: QIAGEN NV - Overview
  • Exhibits183: QIAGEN NV - Product / Service
  • Exhibits184: QIAGEN NV - Key news
  • Exhibits185: QIAGEN NV - Key offerings
  • Exhibits186: Siemens Healthineers AG - Overview
  • Exhibits187: Siemens Healthineers AG - Business segments
  • Exhibits188: Siemens Healthineers AG - Key news
  • Exhibits189: Siemens Healthineers AG - Key offerings
  • Exhibits190: Siemens Healthineers AG - Segment focus
  • Exhibits191: Thermo Fisher Scientific Inc. - Overview
  • Exhibits192: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits193: Thermo Fisher Scientific Inc. - Key news
  • Exhibits194: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits195: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits196: Inclusions checklist
  • Exhibits197: Exclusions checklist
  • Exhibits198: Currency conversion rates for US$
  • Exhibits199: Research methodology
  • Exhibits200: Information sources
  • Exhibits201: Data validation
  • Exhibits202: Validation techniques employed for market sizing
  • Exhibits203: Data synthesis
  • Exhibits204: 360 degree market analysis
  • Exhibits205: List of abbreviations
目次
Product Code: IRTNTR41149

Enzyme-linked Immunosorbent Assay (ELISA) Market 2024-2028

The enzyme-linked immunosorbent assay (ELISA) market is forecasted to grow by USD 843.9 mn during 2023-2028, accelerating at a CAGR of 16.82% during the forecast period. The report on the enzyme-linked immunosorbent assay (ELISA) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing need for frequent diagnostic testing among aging population, rise in toxicology testing in food industry, and increase in chronic diseases.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202414.02%
CAGR16.82%
Incremental Value$843.9 mn

Technavio's enzyme-linked immunosorbent assay (ELISA) market is segmented as below:

By Application

    • Vaccine development
    • Immunology
    • Diagnostics
    • Drug monitoring and pharmaceutical industry
    • Others

By End-user

    • Hospitals and diagnostic centers
    • Research laboratories
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the growing importance of promotional activities as one of the prime reasons driving the enzyme-linked immunosorbent assay (ELISA) market growth during the next few years. Also, increasing cases of cancer and emergence of new disease targets will lead to sizable demand in the market.

The report on the enzyme-linked immunosorbent assay (ELISA) market covers the following areas:

    • Enzyme-linked immunosorbent assay (ELISA) market sizing
    • Enzyme-linked immunosorbent assay (ELISA) market forecast
    • Enzyme-linked immunosorbent assay (ELISA) market industry analysis

The strong vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading enzyme-linked immunosorbent assay (ELISA) market vendors that include Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio RAD Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc., QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. Also, the enzyme-linked immunosorbent assay (ELISA) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Market 2018 - 2022
    • Historic Market Size - Data Table on Global Enzyme-Linked Immunosorbent Assay (Elisa) Market 2018 - 2022 ($ million)
  • 4.2 Application segment analysis 2018 - 2022
    • Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • 4.3 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
    • Chart on Application - Market share 2023-2028 (%)
    • Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 6.3 Vaccine development - Market size and forecast 2023-2028
    • Chart on Vaccine development - Market size and forecast 2023-2028 ($ million)
    • Data Table on Vaccine development - Market size and forecast 2023-2028 ($ million)
    • Chart on Vaccine development - Year-over-year growth 2023-2028 (%)
    • Data Table on Vaccine development - Year-over-year growth 2023-2028 (%)
  • 6.4 Immunology - Market size and forecast 2023-2028
    • Chart on Immunology - Market size and forecast 2023-2028 ($ million)
    • Data Table on Immunology - Market size and forecast 2023-2028 ($ million)
    • Chart on Immunology - Year-over-year growth 2023-2028 (%)
    • Data Table on Immunology - Year-over-year growth 2023-2028 (%)
  • 6.5 Diagnostics - Market size and forecast 2023-2028
    • Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
    • Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
    • Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
    • Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
  • 6.6 Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028
    • Chart on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
    • Data Table on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
    • Chart on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
    • Data Table on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
  • 6.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 7.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 7.3 Hospitals and diagnostic centers - Market size and forecast 2023-2028
    • Chart on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
  • 7.4 Research laboratories - Market size and forecast 2023-2028
    • Chart on Research laboratories - Market size and forecast 2023-2028 ($ million)
    • Data Table on Research laboratories - Market size and forecast 2023-2028 ($ million)
    • Chart on Research laboratories - Year-over-year growth 2023-2028 (%)
    • Data Table on Research laboratories - Year-over-year growth 2023-2028 (%)
  • 7.5 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
  • 12.4 Abcam plc
    • Abcam plc - Overview
    • Abcam plc - Product / Service
    • Abcam plc - Key news
    • Abcam plc - Key offerings
  • 12.5 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
  • 12.6 Avantor Inc.
    • Avantor Inc. - Overview
    • Avantor Inc. - Business segments
    • Avantor Inc. - Key news
    • Avantor Inc. - Key offerings
    • Avantor Inc. - Segment focus
  • 12.7 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
  • 12.8 Bio Rad Laboratories Inc.
    • Bio Rad Laboratories Inc. - Overview
    • Bio Rad Laboratories Inc. - Business segments
    • Bio Rad Laboratories Inc. - Key news
    • Bio Rad Laboratories Inc. - Key offerings
    • Bio Rad Laboratories Inc. - Segment focus
  • 12.9 bioMerieux SA
    • bioMerieux SA - Overview
    • bioMerieux SA - Product / Service
    • bioMerieux SA - Key news
    • bioMerieux SA - Key offerings
  • 12.10 Danaher Corp.
    • Danaher Corp. - Overview
    • Danaher Corp. - Business segments
    • Danaher Corp. - Key news
    • Danaher Corp. - Key offerings
    • Danaher Corp. - Segment focus
  • 12.11 Eppendorf SE
    • Eppendorf SE - Overview
    • Eppendorf SE - Product / Service
    • Eppendorf SE - Key news
    • Eppendorf SE - Key offerings
  • 12.12 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
  • 12.13 Novo Nordisk AS
    • Novo Nordisk AS - Overview
    • Novo Nordisk AS - Business segments
    • Novo Nordisk AS - Key news
    • Novo Nordisk AS - Key offerings
    • Novo Nordisk AS - Segment focus
  • 12.14 Perkin Elmer Inc.
    • Perkin Elmer Inc. - Overview
    • Perkin Elmer Inc. - Business segments
    • Perkin Elmer Inc. - Key news
    • Perkin Elmer Inc. - Key offerings
    • Perkin Elmer Inc. - Segment focus
  • 12.15 QIAGEN NV
    • QIAGEN NV - Overview
    • QIAGEN NV - Product / Service
    • QIAGEN NV - Key news
    • QIAGEN NV - Key offerings
  • 12.16 Siemens Healthineers AG
    • Siemens Healthineers AG - Overview
    • Siemens Healthineers AG - Business segments
    • Siemens Healthineers AG - Key news
    • Siemens Healthineers AG - Key offerings
    • Siemens Healthineers AG - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations